Related Experiment Video
Updated: Nov 6, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8
Chunxiu Hu1, Jianxiang Wu2, Li Wang1
1Department of Cancer Radiotherapy and Chemotherapy, Zhejiang Quhua Hospital, Quzhou, 324004, China.
Objective:
Lung adenocarcinoma (LUAD) is the most common type of lung cancer. This study aims to explore the mechanism by which CDCA8 regulates cell proliferation, invasion, and migration of LUAD, and to generate novel insights into targeted therapy of LUAD.
Methods:
Expression profiles of mature microRNAs (miRNAs) and mRNAs, along with clinical data of LUAD were downloaded from TCGA database for differential analysis and survival analysis to mine differentially expressed mRNAs. qRT-PCR was used to detect the expression of CDCA8 and miR-133b in LUAD cell lines, and western blot was used to detect protein expression. The effects of CDCA8 on the proliferation, migration, and invasion of LUAD cells were detected by CCK-8 assay, scratch healing assay, and Transwell assay. Bioinformatics predicted the target miRNA of CDCA8, and dual-luciferase reporter gene assay was used to verify the binding relationship between miR-133b and CDCA8.
Results:
Data from TCGA-LUAD showed that CDCA8 was significantly overexpressed in LUAD tissue, while its upstream miRNA (miR-133b) was significantly lowly expressed. The result of dual-luciferase test showed that miR-133b targeted CDCA8. The results of in vitro functional experiments showed that overexpression of CDCA8 could promote the proliferation, invasion, and migration of LUAD cells, and miR-133b could reverse this promotion by targeting CDCA8.
Conclusion:
This study found that CDCA8 was a carcinogenic factor in LUAD cells and it was regulated by upstream miR-133b. miR-133b could inhibit proliferation, invasion, and migration of LUAD cells by targeting CDCA8.
Insights
Cell division cycle associated 8 (CDCA8) promotes lung adenocarcinoma (LUAD) growth and spread. MicroRNA-133b (miR-133b) inhibits LUAD by targeting CDCA8, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Lung adenocarcinoma (LUAD) is a prevalent cancer type.
- Understanding the molecular mechanisms driving LUAD progression is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of CDCA8 in LUAD cell proliferation, invasion, and migration.
- To elucidate the regulatory relationship between CDCA8 and miR-133b in LUAD.
- To explore potential therapeutic targets for LUAD.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA) LUAD dataset for gene expression and survival.
- Quantitative reverse transcription PCR (qRT-PCR) and Western blot to assess CDCA8 and miR-133b expression.
- In vitro assays (CCK-8, scratch healing, Transwell) to evaluate cell behavior.
- Bioinformatic prediction and dual-luciferase reporter assay to confirm miR-133b targeting of CDCA8.
Main Results:
- CDCA8 was significantly overexpressed in LUAD tissues, while miR-133b was downregulated.
- miR-133b directly targets and binds to CDCA8.
- Overexpression of CDCA8 enhanced LUAD cell proliferation, invasion, and migration.
- miR-133b overexpression reversed the promoting effects of CDCA8.
Conclusions:
- CDCA8 acts as an oncogene in LUAD, promoting tumor progression.
- miR-133b functions as a tumor suppressor by inhibiting LUAD cell proliferation, invasion, and migration via targeting CDCA8.
- The miR-133b/CDCA8 axis represents a potential therapeutic target for LUAD.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
MicroRNAs
MicroRNAs
Cancer Cell Migration through Invadopodia

